Jeffrey Weidner and Eric Niederkofler will discuss strategies for optimizing dose response assays.

LuZhe Sun will discuss TGFβ signaling during cancer progression and how researchers can target this pathway.

Arnold Levine will discuss his discovery of p53 and the evolution of the field since then, and Jon Chen will discuss the use of single-cell phosphoproteomics in identifying changes in key signaling networks, including p53.

Gene editing can knock out genes crucial to cervical tumor cells’ survival, researchers report.

Studies point to a role for physical activity in fighting malignancies, improving treatment outcomes, and fostering overall health in patients.

Researchers use a new way to deliver CRISPR/Cas9 to tumors in mice, wiping out the cancer.

Researchers use 3-D printing technology to construct a brain cancer model that accurately recapitulated in vivo biology and predicted patient drug responses.

How researchers create a glioblastoma on a chip that can predict patients’ response to treatments

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.